✦ LIBER ✦

Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial

✍ Scribed by Sartor, Oliver; Coleman, Robert; Nilsson, Sten; Heinrich, Daniel; Helle, Svein I; O'Sullivan, Joe M; Fosså, Sophie D; Chodacki, Aleš; Wiechno, Paweł; Logue, John; Widmark, Anders; Johannessen, Dag Clement; Hoskin, Peter; James, Nicholas D; Solberg, Arne; Syndikus, Isabel; Vogelzang, Nicholas J; O'Bryan-Tear, C Gillies; Shan, Minghua; Bruland, Øyvind S; Parker, Christopher

Book ID: 122133016
Publisher: The Lancet
Year: 2014
Tongue: English
Weight: 527 KB
Volume: 15
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(14)70183-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radium-223 Dichloride (Ra-223) Impact on

Radium-223 Dichloride (Ra-223) Impact on Skeletal-Related Events, External Beam Radiation Therapy (EBRT), and Pain in Patients With Castration-Resistant Prostate Cancer (CRPC) With Bone Metastases: Updated Results From the Phase 3 ALSYMPCA Trial

✍ Michalski, J.; Sartor, O.; Parker, C.; Shan, M.; Garcia-Vargas, J.; Aksnes, A.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 64 KB

865 Effects of radium-223 dichloride (Ra

865 Effects of radium-223 dichloride (Ra-223) on total alkaline phosphatase (ALP) and prostate-specific antigen (PSA) in patients with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases from the phase 3 ALSYMPCA trial

✍ Heinrich, D.; Parker, C.; Shan, M.; Wilhelm, S.; Garcia-Vargas, J.; O'Bryan-Tear 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 111 KB

101 Updated analysis of radium-223 dichl

101 Updated analysis of radium-223 dichloride (Ra-223) impact on pain, skeletal-related events (SRE), and survival from the phase 3 randomized trial (ALSYMPCA) in patients with castration-resistant prostate cancer (CRPC) and bone metastases

✍ Heinrich, D.; Helle, S.I.; Chodacki, A.; Wiechno, P.; Garcia-Vargas, J.; Staudac 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 110 KB

P124 Long-term safety of radium-223 dich

P124 Long-term safety of radium-223 dichloride (Ra-223) in patients with castration-resistant prostate cancer (CRPC) and bone metastases from the phase 3 ALSYMPCA study

✍ Nilsson, S; Schrader, A.J.; Kliment, J.; Solberg, A.; Franzén, L.; Bottomley, D. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 66 KB

684 RADIUM-223 CHLORIDE (ALPHARADIN) IMP

684 RADIUM-223 CHLORIDE (ALPHARADIN) IMPACT ON OVERALL SURVIVAL AND SKELETAL-RELATED EVENTS IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER WITH BONE METASTASES A PHASE III RANDOMIZED TRIAL (ALSYMPCA)

✍ Sartor, Oliver; Heinrich, Daniel; Helle, Svein Inge; O'Sullivan, Joe M.; Chodack 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB

A Randomized, Double-Blind, Dose-Finding

A Randomized, Double-Blind, Dose-Finding, Multicenter, Phase 2 Study of Radium Chloride (Ra 223) in Patients with Bone Metastases and Castration-Resistant Prostate Cancer

✍ Christopher C. Parker; Sarah Pascoe; Aleš Chodacki; Joe M. O'Sullivan; Josep R. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 930 KB